Meridian Bioscience, Inc. (VIVO)
NASDAQ: VIVO · IEX Real-Time Price · USD
32.65
+0.10 (0.31%)
Aug 12, 2022 2:29 PM EDT - Market open
VIVO Market Cap
VIVO has a market cap or net worth of $1.43 billion as of August 12, 2022, making it the 2,296th biggest public company in the US. VIVO's market cap has increased by +61.80% in one year.
Market Cap
1.43B
Enterprise Value
1.38B
1-Year Change
+61.80%
Ranking
Category
Small-Cap
Stock Price
$32.65
Market Cap Chart
Since July 29, 1986, VIVO's market cap has increased from $19.61 million to $1.43 billion, an increase of 7,185.34%. That is a compound annual growth rate of 12.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2022 | 1.43B | 0.25% |
Aug 9, 2022 | 1.42B | 0.15% |
Aug 8, 2022 | 1.42B | 0.09% |
Aug 5, 2022 | 1.42B | 2.79% |
Aug 4, 2022 | 1.38B | -2.05% |
Aug 3, 2022 | 1.41B | 2.67% |
Aug 2, 2022 | 1.38B | -0.95% |
Aug 1, 2022 | 1.39B | 0.25% |
Jul 29, 2022 | 1.38B | -0.97% |
Jul 28, 2022 | 1.40B | -1.66% |
Jul 27, 2022 | 1.42B | 0.78% |
Jul 26, 2022 | 1.41B | -1.04% |
Jul 25, 2022 | 1.43B | -0.03% |
Jul 22, 2022 | 1.43B | -0.25% |
Jul 21, 2022 | 1.43B | 1.84% |
Jul 20, 2022 | 1.40B | -0.89% |
Jul 19, 2022 | 1.42B | 0.99% |
Jul 18, 2022 | 1.40B | -0.95% |
Jul 15, 2022 | 1.42B | -0.06% |
Jul 14, 2022 | 1.42B | -1.67% |
Jul 13, 2022 | 1.44B | -0.15% |
Jul 12, 2022 | 1.44B | 0.43% |
Jul 11, 2022 | 1.44B | -0.06% |
Jul 8, 2022 | 1.44B | -0.81% |
Jul 7, 2022 | 1.45B | -0.84% |
View and export this data all the way back to 1986.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition
Related Stocks
Company | Market Cap |
---|---|
Atrion | 1.16B |
Cronos Group | 1.20B |
Natus Medical | 1.14B |
Madrigal Pharmaceuticals | 1.25B |
Revolution Medicines | 2.22B |
Zentalis Pharmaceuticals | 1.60B |
Outset Medical | 1.01B |
RadNet | 1.26B |
Agios Pharmaceuticals | 1.56B |
NGM Biopharmaceuticals | 1.38B |